#Asia

This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.

A recent mid-stage trial that combined coblopasvir with Sovaldi (sofosbuvir) boasted a high cure rate.

Women with a history of the malignancy also survive longer than men after receiving a liver transplant.

This finding concerns liver cancer diagnosed after being cured of hepatitis C.

Researchers analyzed cancer outcomes among a large group of South Koreans with hepatitis B virus.

Researchers analyzed the association between heavy drinking and immune function in those with untreated HIV.

An analysis conducted in Taiwan analyzed health outcomes over more than a decade.

Researchers found that this association was statistically significant beginning five years after treatment.

A recent study tested the effectiveness and tolerability of Technivie (ombitasvir/paritaprevir/ritonavir) among those over 65.

Researchers compared direct-acting-antiviral treatment outcomes between those with and without a history of liver cancer.

Researchers analyzed a cohort of South Koreans taking Viread (tenofovir disoproxil fumarate) or Baraclude (entecavir) for hepatitis B.

These rates are driven in large part by hepatitis B and C.

And can treating the virus reduce the risk of chronic kidney and cardiovascular diseases as well as the risk of death from such causes?

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

Some countries, such as Australia and the United Kingdom, permit people to import generic drugs for personal use.

National surveys also show more than 70 percent of the 800,000 people in the U.S. currently affected by hep B are foreign-born.